LIGAND PHARMACEUTICALS INC ($LGND)
Filing Information
| Accession Number | 0002001011-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 7, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
467
Total Value
$88,532.49
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 2, 2026 | Sale | 21 | $186.59 | $3,918.39 | 44,100 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 2, 2026 | Sale | 91 | $187.95 | $17,103.78 | 44,009 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 2, 2026 | Sale | 102 | $188.96 | $19,274.20 | 43,907 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 2, 2026 | Sale | 207 | $190.27 | $39,385.95 | 43,700 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 2, 2026 | Sale | 46 | $192.40 | $8,850.17 | 43,654 | Direct | โ | View Details |